NO944339D0 - Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser - Google Patents

Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser

Info

Publication number
NO944339D0
NO944339D0 NO944339A NO944339A NO944339D0 NO 944339 D0 NO944339 D0 NO 944339D0 NO 944339 A NO944339 A NO 944339A NO 944339 A NO944339 A NO 944339A NO 944339 D0 NO944339 D0 NO 944339D0
Authority
NO
Norway
Prior art keywords
sleep disorders
treatment
melatonin derivatives
melatonin
derivatives
Prior art date
Application number
NO944339A
Other languages
English (en)
Other versions
NO944339L (no
NO309964B1 (no
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO944339D0 publication Critical patent/NO944339D0/no
Publication of NO944339L publication Critical patent/NO944339L/no
Publication of NO309964B1 publication Critical patent/NO309964B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO944339A 1993-11-18 1994-11-14 Anvendelse av melatoninderivater for fremstilling av et medikament for behandling av søvnforstyrrelser NO309964B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,332 US5654325A (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating sleep disorders

Publications (3)

Publication Number Publication Date
NO944339D0 true NO944339D0 (no) 1994-11-14
NO944339L NO944339L (no) 1995-05-19
NO309964B1 NO309964B1 (no) 2001-04-30

Family

ID=22550932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944339A NO309964B1 (no) 1993-11-18 1994-11-14 Anvendelse av melatoninderivater for fremstilling av et medikament for behandling av søvnforstyrrelser

Country Status (21)

Country Link
US (1) US5654325A (no)
EP (1) EP0655243B1 (no)
JP (1) JPH07196493A (no)
KR (1) KR950013508A (no)
CN (1) CN1092958C (no)
AT (1) ATE222491T1 (no)
AU (1) AU684313B2 (no)
CA (1) CA2135709C (no)
CZ (1) CZ288835B6 (no)
DE (1) DE69431199T2 (no)
DK (1) DK0655243T3 (no)
ES (1) ES2181702T3 (no)
HU (1) HUT72069A (no)
IL (1) IL111580A (no)
NO (1) NO309964B1 (no)
NZ (1) NZ264892A (no)
PH (1) PH31098A (no)
PT (1) PT655243E (no)
RU (1) RU2146140C1 (no)
SG (1) SG50505A1 (no)
ZA (1) ZA948927B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (en) * 1995-06-14 1997-05-21 Lilly Co Eli Melatonin agonists for the treatment of benign forms of hyperplasia of the prostate
CA2357114C (en) * 2001-03-22 2010-06-29 Pooger Properties Ltd. Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US20060167050A1 (en) * 2002-09-26 2006-07-27 Pooger Properties Limited Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
WO2005062851A2 (en) * 2003-12-22 2005-07-14 Pappolla Miguel A Indole-3-propionamide and derivatives thereof
CA2556753C (en) * 2004-02-20 2014-11-25 Lifescape Biosciences Incorporated Compositions and methods for sleep regulation
DE102005008312A1 (de) * 2005-02-17 2006-08-24 Birds Pharma Gmbh Berolina Innovative Research & Development Services Verwendung deuterierter N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]acatamide und deren pharmazeutisch verträglicher Salze sowie diese Verbindungen enthaltende Arzneimittel
US20060223877A1 (en) * 2005-03-31 2006-10-05 Zemlan Frank P Methods of treatment utilizing certain melatonin derivatives
AR061478A1 (es) 2006-06-19 2008-08-27 Takeda Pharmaceutical Compuesto triciclico y composicion farmaceutica
ES2324849A1 (es) * 2007-10-25 2009-08-17 Ferrer Internacional, S.A. Compuestos de indano.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
EP0126630B1 (en) * 1983-05-18 1987-09-16 Monash University The use of melatonin for the manufacture of a medicament
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
US5093352A (en) * 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
AU616907B2 (en) * 1987-08-17 1991-11-14 Whitby Research, Inc. Melatonin analogues
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
JPH07503232A (ja) * 1991-10-18 1995-04-06 アルザ・コーポレーション メラトニンの制御経皮投与
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
CA2135709A1 (en) 1995-05-19
ZA948927B (en) 1996-05-10
HU9403300D0 (en) 1995-01-30
ATE222491T1 (de) 2002-09-15
CZ276594A3 (en) 1995-07-12
EP0655243A2 (en) 1995-05-31
US5654325A (en) 1997-08-05
RU2146140C1 (ru) 2000-03-10
SG50505A1 (en) 1998-07-20
PH31098A (en) 1998-02-05
IL111580A0 (en) 1995-01-24
DE69431199D1 (de) 2002-09-26
CZ288835B6 (cs) 2001-09-12
NO944339L (no) 1995-05-19
RU94040886A (ru) 1996-09-20
NO309964B1 (no) 2001-04-30
EP0655243B1 (en) 2002-08-21
DE69431199T2 (de) 2003-03-27
ES2181702T3 (es) 2003-03-01
HUT72069A (en) 1996-03-28
CN1092958C (zh) 2002-10-23
EP0655243A3 (en) 1995-10-11
CA2135709C (en) 2007-01-02
AU684313B2 (en) 1997-12-11
PT655243E (pt) 2002-11-29
AU7777794A (en) 1995-05-25
JPH07196493A (ja) 1995-08-01
CN1107701A (zh) 1995-09-06
IL111580A (en) 1999-10-28
KR950013508A (ko) 1995-06-15
DK0655243T3 (da) 2002-10-07
NZ264892A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
LTIP919A (en) Drugs and process for preparing thereof
NO944339D0 (no) Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
NO944340L (no) Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
ATE201993T1 (de) Verwendung von olanzapine zur herstellung eines arzneimittels zur behandlung der zerebralen fokalen ischämie
PT1304107E (pt) Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
ITMI920106A0 (it) Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista atte al trattamento dei disordini cerebro-vascolari

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees